Big pharmaceutical companies compete for strength

Recently, large multinational pharmaceutical companies have successively released their 2021 annual reports.
How is the growth of large pharmaceutical companies? What is the main business support?

1.
Johnson & Johnson has the largest scale, and Pfizer has the highest growth rate

Among all large multinational pharmaceutical companies, Johnson & Johnson's total sales revenue in 2021 will reach $93.
775 billion, ranking among the top in the industry
.

Driven by the growth in sales of the new crown vaccine, Pfizer's revenue in 2021 will increase by 95% year-on-year to $81.
288 billion
.

2.
Competition in the field of tumor and immunity

In most large multinational pharmaceutical companies, the oncology and autoimmune disease businesses are becoming the main source of revenue for the company
.

In the field of oncology, Bristol-Myers Squibb (BMS)'s oncology business revenue will reach US$30.
196 billion in 2021, accounting for 65% of the company's pharmaceutical business revenue
.

In the field of autoimmune diseases, with Humira's huge revenue ($20.
694 billion), AbbVie's autoimmune disease business ranks first among major pharmaceutical companies with $25.
284 billion, accounting for 45% of the company's pharmaceutical business revenue
.

3.
Who is the strongest in business in China?

Among the large multinational pharmaceutical companies that independently announced their sales revenue in China, the total revenue of Roche and AstraZeneca in China was US$6.
165 billion and US$6.
011 billion, respectively, with a growth rate of 12.
8% and 12%, which is indistinguishable
.

However, in 2021, Roche, AstraZeneca, Merck, Sanofi, Novartis, Novo Nordisk, and Eli Lilly will maintain a balance or increase in the proportion of sales revenue in China to global sales revenue